Hepatic tumors: Region-of-interest versus volumetric analysis for quantification of attenuation at CT

Radiology

Volumn 262, Issue 3, 2012, Pages 853-861

  Chalian, Hamid ^a   Tochetto, Sandra M ^a   Töre, Hüseyin G ^a   Rezai, Pedram ^a   Yaghmai, Vahid ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE DISPLAY; INTERMETHOD COMPARISON; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION ATTENUATION; REPRODUCIBILITY; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84858735870     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110106     Document Type: Article

References (34)

1. Schima W, Kulinna C, Langenberger H, Ba-Ssalamah A. Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging 2005;5 Spec No A:S149-S156.
2. Yaghmai V, Miller FH, Rezai P, Benson AB 3rd, Salem R. Response to treatment series. II. Tumor response assessment: using new and conventional criteria. AJR Am J Roentgenol 2011;197(1):18-27.
3. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45(2):228-247.
4. Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet 2000;356(9227):373-378. (Pubitemid 30487493)
5. Jain RK, Duda DG, Willett CG, et al. Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol 2009;6(6):327-338.
6. Suzuki C, Jacobsson H, Hatschek T, et al. Radiologic measurements of tumor response to treatment: practical approaches and limitations. RadioGraphics 2008;28(2): 329-344.
7. Wang JH, Min PQ, Wang PJ, et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. AJR Am J Roentgenol 2006;186(5):1423-1430.
8. Yi CA, Lee KS, Kim EA, et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004;233(1):191-199. (Pubitemid 39280974)
9. Choi H, Charnsangavej C, de Castro Faria S, et al. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol 2004;183(6): 1619-1628. (Pubitemid 44210530)
10. Choi H, Charnsangavej C, Faria SC, et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007;25(13):1753-1759. (Pubitemid 46797957)
11. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009;250(2): 407-416.
12. Hattori Y, Gabata T, Matsui O, et al. Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol 2009;15(25):3114-3121.
13. Tochetto SM, Rezai P, Rezvani M, et al. Does multidetector CT attenuation change in colon cancer liver metastases treated with 90Y help predict metabolic activity at FDG PET? Radiology 2010;255(1):164-172.
14. Marcus CD, Ladam-Marcus V, Cucu C, Bouché O, Lucas L, Hoeffel C. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives. Crit Rev Oncol Hematol 2009;72(3):217-238.
15. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10(3):254-259. (Pubitemid 29463107)
16. Kuhnigk JM, Dicken V, Bornemann L, et al. Morphological segmentation and partial volume analysis for volumetry of solid pulmonary lesions in thoracic CT scans. IEEE Trans Med Imaging 2006;25(4):417-434.
17. Keil S, Behrendt FF, Stanzel S, et al. Semiautomated measurement of hyperdense, hypodense and heterogeneous hepatic metastasis on standard MDCT slices: comparison of semi-automated and manual measurement of RECIST and WHO criteria. Eur Radiol 2008;18(11):2456-2465.
18. Moltz JH, Bornemann L, Kuhnigk JM, et al. Advanced segmentation techniques for lung nodules, liver metastases, and enlarged lymph nodes in CT scans. IEEE J Sel Top Signal Process 2009;3(1):122-134.
19. Bornemann L, Kuhnigk JM, Dicken V, et al. Informatics in radiology (infoRAD): new tools for computer assistance in thoracic CT. II. Therapy monitoring of pulmonary metastases. RadioGraphics 2005;25(3): 841-848. (Pubitemid 40826802)
20. Bornemann L, Dicken V, Kuhnigk JM, et al. OncoTREAT: a software assistant for cancer therapy monitoring. Int J Comput Assist Radiol Surg 2007;1(5):231-242.
21. Soyer P, Poccard M, Boudiaf M, et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 2004;231(2): 413-420. (Pubitemid 38552898)
22. Miller FH, Butler RS, Hoff FL, Fitzgerald SW, Nemcek AA Jr, Gore RM. Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. AJR Am J Roentgenol 1998;171(3):643-649. (Pubitemid 28406124)
23. Keil S, Plumhans C, Behrendt FF, et al. Semi-automated quantification of hepatic lesions in a phantom. Invest Radiol 2009;44(2):82-88.
24. Demehri S, Kalra MK, Rybicki FJ, et al. Quantification of urinary stone volume: attenuation threshold-based CT method - a technical note. Radiology 2011;258(3):915-922.
25. Mantha S, Roizen MF, Fleisher LA, Thisted R, Foss J. Comparing methods of clinical measurement: reporting standards for Bland and Altman analysis. Anesth Analg 2000;90(3):593-602. (Pubitemid 30117518)
26. Cuenod CA, Fournier L, Balvay D, Guinebretière JM. Tumor angiogenesis: pathophysiology and implications for contrastenhanced MRI and CT assessment. Abdom Imaging 2006;31(2):188-193.
27. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9(6):713-725. (Pubitemid 36749220)
28. Goh V, Halligan S, Daley F, Wellsted DM, Guenther T, Bartram CI. Colorectal tumor vascularity: quantitative assessment with multidetector CT - do tumor perfusion measurements reflect angiogenesis? Radiology 2008;249(2):510-517.
29. Sahani DV, Holalkere NS, Mueller PR, Zhu AX. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue - initial experience. Radiology 2007;243(3): 736-743. (Pubitemid 46799427)
30. Ng QS, Goh V, Fichte H, et al. Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology 2006;239(2): 547-553.
31. Pauls S, Gabelmann A, Heinz W, et al. Liver perfusion with dynamic multidetector-row computed tomography as an objective method to evaluate the efficacy of chemotherapy in patients with colorectal cancer. Clin Imaging 2009;33(4): 289-294.
32. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 2006;16(1):80-87. (Pubitemid 43103572)
33. Miller FH, Keppke AL, Reddy D, et al. Response of liver metastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR Am J Roentgenol 2007;188(3):776-783.
34. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35(3):421-430. (Pubitemid 32844200)